Talis Biomedical (TLIS) News Today → Banking Apocalypse Ahead: Secure Your Savings Today! (From Weiss Ratings) (Ad) Free TLIS Stock Alerts $9.02 +0.02 (+0.22%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | investing.comTalis Biomedical Corp (TLIS)May 8, 2024 | investorplace.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024March 31, 2024 | finance.yahoo.comTalis Biomedical Corporation (TLIS)February 16, 2024 | markets.businessinsider.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 15, 2024 | finance.yahoo.comTLIS Feb 2024 2.500 putNovember 14, 2023 | bizjournals.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | finanznachrichten.deTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | msn.comLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comTalis reviewing strategic alternatives, stock rallies 35%November 14, 2023 | msn.comWhy Talis Biomedical (TLIS) Stock Is Exploding HigherNovember 14, 2023 | finance.yahoo.comTalis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | marketbeat.comTrading was temporarily halted for "TLIS" at 07:11 AM with a stated reason of "News pending."August 16, 2023 | msn.comBTIG Maintains Talis Biomedical (TLIS) Sell RecommendationAugust 16, 2023 | markets.businessinsider.comBTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To KnowAugust 11, 2023 | finance.yahoo.comTalis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateAugust 9, 2023 | benzinga.comA Preview Of Talis Biomedical's EarningsAugust 3, 2023 | finance.yahoo.comTalis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023August 2, 2023 | finance.yahoo.comTalis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)August 1, 2023 | uk.finance.yahoo.comTLIS - Talis Biomedical CorporationJuly 24, 2023 | finance.yahoo.comTalis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 5, 2023 | finance.yahoo.comTalis Biomedical Announces 1-for-15 Reverse Stock SplitMay 23, 2023 | finance.yahoo.comTalis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorMay 12, 2023 | finanznachrichten.deTalis Biomedical Corporation: Talis Biomedical Announces Business Update and First Quarter 2023 Financial ResultsMay 11, 2023 | seekingalpha.comTalis Biomedical reports Q1 resultsMay 11, 2023 | msn.comTalis Biomedical: Q1 Earnings InsightsMay 9, 2023 | benzinga.comTalis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of ShareholdersMay 6, 2023 | benzinga.comTalis Biomedical Stock (NASDAQ:TLIS), DividendsMay 4, 2023 | finance.yahoo.comTalis Biomedical to Provide Business Update and Financial Results on May 11, 2023May 2, 2023 | benzinga.comTalis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of ShareholdersApril 4, 2023 | markets.businessinsider.comBTIG Remains a Sell on Talis Biomedical (TLIS)April 1, 2023 | seekingalpha.comTLIS Talis Biomedical CorporationMarch 31, 2023 | markets.businessinsider.comTalis Biomedical Corporation Registered ShsMarch 24, 2023 | bizjournals.comChan Zuckerberg Biohub takes space at Chicago's Fulton Labs CampusMarch 23, 2023 | finanznachrichten.deTalis Biomedical Corporation: Talis Announces Fourth Quarter and Full Year 2022 Financial ResultsNovember 9, 2022 | finance.yahoo.comTalis Biomedical Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsNovember 4, 2022 | finance.yahoo.comTalis Biomedical Reports Third Quarter 2022 Financial ResultsAugust 22, 2022 | nasdaq.comCompanies Like Talis Biomedical (NASDAQ:TLIS) Could Be Quite RiskyAugust 8, 2022 | finance.yahoo.comWinner of Trump-era Covid test competition to cut 57 jobs, shift into women's and sexual health testsAugust 5, 2022 | seekingalpha.comTalis Biomedical Corporation (TLIS) CEO Rob Kelly on Q2 2022 Results - Earnings Call TranscriptAugust 3, 2022 | finance.yahoo.comTalis Biomedical Stops Work On COVID-19 Assay, Cuts WorkforceAugust 2, 2022 | finance.yahoo.comTalis Biomedical Provides Business Update and Reports Second Quarter Financial ResultsJune 14, 2022 | benzinga.comTalis Biomedical Earnings Perspective: Return On Capital EmployedMay 15, 2022 | seekingalpha.comTalis Biomedical Corporation(TLIS) CEO Rob Kelly on Q12022 Results - Earnings Call TranscriptMay 12, 2022 | fool.comTalis Biomedical Corporation (TLIS) Q1 2022 Earnings Call TranscriptMay 10, 2022 | finance.yahoo.comTalis Biomedical Announces First Quarter 2022 Financial ResultsMay 10, 2022 | finance.yahoo.comCan Talis Biomedical (NASDAQ:TLIS) Afford To Invest In Growth?April 26, 2022 | finance.yahoo.comTalis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022April 26, 2022 | finance.yahoo.comTalis Biomedical stock bounces off record low after largest shareholder pulls share-sale plansMarch 23, 2022 | finance.yahoo.comTalis Biomedical Corporation (TLIS) Q4 2021 Earnings Call TranscriptMarch 18, 2022 | marketbeat.comTalis Biomedical (NASDAQ:TLIS) Cut to "Sell" at BTIG ResearchBTIG Research cut shares of Talis Biomedical from a "neutral" rating to a "sell" rating in a research note on Friday. Get Talis Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here TLIS Media Mentions By Week TLIS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLIS News Sentiment▼1.880.86▲Average Medical News Sentiment TLIS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLIS Articles This Week▼20▲TLIS Articles Average Week Get Talis Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HLTH News AXDX News TBIO News OMIC News RPID News LUCD News PRE News AIH News CDIO News PLAG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLIS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
